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Introduction
Problem statement 
In this paper, a research study is performed on an experimental 
management treatment possibility to Autism Spectral Disorder 
(ASD) making use of musical Neurofeedback (NF). The Brain 
Music System (BMS) was used in conjunction with a two channel 
electroencephalography (EEG) device headband with the intent to 
suppress Delta (δ) waves in the subject’s brain.
Autism spectral disorder
ASD is a disorder characterized by impairments in social 
interaction, verbal communication and repetitive behaviours 
(European Commission [1]). It affects around 60 children out of 1000 
[2], of which mostly are below the age of 8 years. No treatment has been 
found to cure ASD, however, the disorder is controllable with the use of 
several treatment methodologies [1]. In the literature reviewed we see 
how several treatments tend to improve the patients’ life leading to the 
point where the child grows up to live a normal or near normal life [1].
There are two main types of treatments for ASD; Ingestible 
(orally administered e.g. taking pills) and noningestible (externally 
administered e.g. psychiatry) [3]. Studies indicate that the most effective 
noningestible treatments are specialized and supportive educational 
programs tailor-made for children suffering from ASD [3,4]. In fact, 
one of the most effective specialized programs is speech and language 
therapy [5]. 
The only Food and Drug Administration (FDA) approved 
medication for ASD treatment are Risperidone and Aripiprazole 
and are only approved to be used in children between the ages of 5 
and 16 [3]. Any other medication used in treating ASD are targeted 
to treat secondary effects caused by ASD such as sleep deprivation, 
hyperactivity, anxiety, aggression, disruptive behaviour and self-
injuries [3]. However, these sort of ingestible therapies are known to 
cause several other problems and side effects [3].
Literature suggests that children diagnosed with ASD have 
different brain activity levels when compared to normally developing 
children. A study on 50 children (27 diagnosed with ASD and 23 
controls) concluded that children with ASD have higher levels of δ 
waves amongst other abnormalities which support the imbalance of 
neural excitation in an Autistic brain [6].
Neurofeedback
NF has now been used for several years in research, clinical trials 
and as treatment for several conditions and disorders [7]. NF makes use 
of the user’s EEG gathered data to modify the neurophysiological and 
neurological basis for a number of neurological based disorders [7]. 
NF proved to be helpful for a number of neurological disorders [8,9]. 
Research on the effects of NF performed on patients diagnosed with ASD 
show that improvements in social behaviour and electrophysiological 
behaviour are obtained in several cases [3,10]. Other research studies 
imply that NF has no or little effect in treating ASD [11].
Two channel EEG device and the Brain Music System
As a preamble to the analysis of obtained results a general 
introduction on the two channel EEG device headband and the BMS is 
presented. The two channel EEG device headband developed by AAT 
Research, is a portable two electrode EEG signal acquisition device which 
uses a modified version of the low resolution brain electromagnetic 
tomography (LORETA) to obtain estimates of subcortical activity. 
This device can connect to a computer via Bluetooth such that it can 
be interfaced to the BMS application running on the same machine. 
The BMS is a software application that uses Sonified Neurofeedback 
to convert the EEG signals obtained from the headband into Sonified 
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signals (binaural beats). These musical waveforms are presented back 
to the user forming a loop in attempt to level the brainwaves in real-
time according to the respective mental state [12]. The NF music trains 
the brain in attaining a pleasant frequency of brain activity [13,14].
The basic composition of the whole system used as therapy is 
represented by a detailed block diagram in Figure 1.
EEG is the measure of the electrical activity of the brain and is 
widely represented using the LORETA algorithm [15]. The LORETA 
algorithm was first introduced in 1994 as 3D, linear solution to the 
inverse EEG/MEG problem [16].
The two-channel EEG headband device makes use of just two dry 
electrodes; one placed on the frontal left hemisphere and the other 
placed on the frontal right hemisphere of the subject’s head to collect 
EEG data [13,14]. The signal gathered from the electrodes is processed 
using a modified version of the LORETA algorithm [13,14]. The 
latter mentioned algorithm uses the EEG data gathered from the two 
electrodes to predict, estimate and virtually create 14 other channels. 
The output data from the EEG headband device is saved in EDF file 
format (which is the European Standard EEG data file format) [13,14].
Aims and objectives
The aim of combining the two channel EEG device and BMS is 
to create a user friendly, portable and reduced cost platform as an aid 
to people diagnosed with ASD. Such a person would generally have 
increased levels of δ waveforms when awake, which are normally found 
in a healthy person’s brain activity sleep patterns. The BMS aims to 
suppress δ waveforms while promoting Alpha (α) and Beta (β) waves, 
which are respectively associated with focus and mental activity. 
The intention of this study is to analyse the effect of the two channel 
EEG device and the BMS combined together over a group of subjects 
diagnosed with ASD.
Testing
Two channel EEG device SNR testing
A coherence test was carried out on the two channel EEG device 
headband in a sterile clean room environment. The test was performed 
using the in-house clean room for a sterile environment, a dBA (sound 
Amplitude) meter, a set of speakers which could be calibrated to 
produce a certain dBA sound and tailor-made software designed to 
produce pure tone sounds at various frequencies while recording the 
response from the two channel EEG device sensors.
The test was carried out by recording readings from the headband 
while pure tones at frequencies 256 Hz, 512 Hz 1 kHz, 3 kHz, 5 kHz, 7 
kHz and 10 kHz were played sequentially. The whole testing procedure 
was repeated twice at 80 dB amplitude and 92 dB amplitude. In addition, 
a reading was also taken of background noise since perfect silence in 
the clean room could not be obtained and thus the background noise 
was common in all readings. This background noise was found to have 
an amplitude of 57 dB. The recorded signals from the two channel EEG 
device sensors were saved and used for analyses.
Seven plots were obtained from the results gathered. Each plot was 
constructed from background noise data and the response of the device 
at 80 dBA and 92 dBA for each frequency respectively (Figures 2-4).
Figure 5 shows some of the several plots constructed. These prove 
that the output recorded with respect to different dBA and same 
frequency input tone, is coherent. This validates the results that the 
sensor produces.
Participant selection
For a subject to be considered to participate in this long term 
 
Figure 1: Block diagram of the Brain Music System used as a Neurofeedback 
therapy.
 
Figure 2: Sterile environment used for testing procedure.
 
Figure 3: Testing setup.
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clinical trial a number of requirements had to be met. This was done 
with reference to participant selection done for Autistic clinical 
trials performed by the U.S. National Institutes of Health [17] and a 
similar clinical trial selection process to that performed by the Yukon 
Government (Canada) for clinical trials [18].
To be eligible for the clinical trial presented, the following 
requirements had to be met:
Age: Between 2 Years and 40 Years 
Gender: both 
The participant had to be diagnosed with ASD or Asperger’s 
Disorder. 
Participants were considered as non-eligible if they suffered from 
hearing impairment. 
Presentation of test data
The test considered in this paper is based on nine subjects using 
the two channel EEG device and BMS in unknown non-controlled 
environment such as the test subject’s personal household. Participants 
in this study signed a disclaimer and submitted their reports daily. No 
remuneration was given to the subjects in this study. Also, none of the 
members of the staff had direct access to both the subjects and their 
reports respectively.
Participants in this study are all aged between 6 and 18 years 
and have all been diagnosed with ASD, although the severity of the 
condition’s diagnosis varies from Pervasive, Asperger’s Syndrome to 
Classical Autism. Since the subjects submitted their reports voluntarily, 
the regularity of BMS report submission, as well as the total amount of 
reports submitted varies with the test subject. Due to possible variability 
in the data and amount of data sets between subjects, the obtained BMS 
reports are not analysed across subjects but analysis of test results is 
performed on each data set independently.
Nine subjects were in accordance to the participant selection policy 
employed in this study; however, only eight were accepted while the 
other subject was eliminated due to the lack of reports submitted. The 
first 10 session reports of each participant were not considered for 
analysis in order to give the participants enough time for adaptation.
Furthermore, from all eight accepted subjects, the focus of analysis 
was done on a particular one of them. This is due to the highest testing 
data reports obtained from the subject. A total of 124 reports were 
submitted for analysis from this particular subject.
Procedure
Each session accepted for analysis in this paper involves the test 
subject’s usage of the two channel EEG device and the BMS for a 
fixed 40 minute pre-programmed session for not more than once per 
day. Such a session involves the user wearing the two channel EEG 
device headband with the two electrodes placed symmetrically on 
the frontal lobe. The user then connects to the BMS and undergoes a 
session while sitting down and wearing headphones. Furthermore the 
user was asked to minimize eye blinking and movement in order to 
reduce artefact generation on the EEG signal obtained. As the session 
ends, the user is provided with a report in Portable Document Format 
(PDF). This document is conveyed to AAT Research and analysis is 
performed on the waveforms presented in this report. These PDF type 
reports were converted to a Portable Network Graphics (PNG) type 
of image in order to extract data from the PNG images using image 
processing techniques. To do this, an algorithm was built in which a 
set of PNG report images were selected for analysis. Each report was 
cropped in such a way that only α, β and δ waves are left of the original 
report image. The image now obtained, has a binarization procedure 
performed on the respective red (R), green (G) & blue (B) images using 
a threshold of 0.86. This provided us with images of α, β & δ waveforms 
independently. The respective waveform images’ bounding box 
coordinates were detected and each image was scanned horizontally 
to detect the amount of voltage peaks occurred during the respective 
session of every wave type i.e. α, β & δ. A peak is defined as a rapid 
change in voltage from baseline voltage exceeding a certain threshold 
set.
 
Figure 4: Testing procedure.
 
Figure 5: Plotting outputs of the same frequency tones at 80 dB, 92 
dB and 57dB background noise for (a):7k Hz, (b): 1k Hz & (c): 5k Hz.
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Moreover, parents of the children participating in this study were 
given a question to answer to have direct feedback on the progress of 
the child using the two channel EEG device headband and BMS system.
Results
Refer to (Tables 1-4) and (Figures 6-22).
Analysis and Discussion
δ waves, which in a healthy normal person are recorded during 
deep sleep (stage 3 & stage 4) [19], tend to be at high levels at all times 
in persons diagnosed with ASD, even while they are awake [19]. In 
a study done to compare normally developing children and children 
diagnosed with ASD, it was concluded that brain asymmetry activity 
in children with ASD is caused by higher δ wave activity [20]. With 
reference to this result, in the presented study, δ waves are being 
suppressed. Suppression of these δ waves could be seen in Figure 22.
Results displayed in Figures 14,15 and 22 show how δ wave peaks 
tend to have lowered in peak levels in the respective time in which the 
respective subject is using the 2 channel EEG headband with the BMS. 
A significant improvement could be seen when comparing the δ peak 
levels in the first session to that in the last session reported.
Analyzing Figures 16,17 and 20, we can conclude that during the 
periods in which the subjects are being analyzed, all participants tend to 
have increased levels of α wave peaks over time. α waves are produced 
in state of relaxation and closing eyes [19]. As a result, it could be 
concluded that the subjects being studied in this paper tend to be more 
relaxed over time. With reference to the cause of lateral asymmetry in 
the brain presented by Stroganova et al. [20], increasing α waves apart 
from decreasing δ waves helps to compensate for the lower activity and 
higher activity from the respective hemispheres.
β waves are associated with focusing activities [19]. Results 
illustrated in Figures 18,19 and 21 demonstrate how the subjects’ levels 
of β wave peaks increase over time while using the two channel EEG 
device and BMS device. Due to this promotion of β waves, subjects 
Gender Medical Condition Specify your experience on the therapy’s 
effectiveness 
Male Autism More attention, more calm, less tantrums, but zero 
improvement in speech 
Female Autism Longer concentration span, happier, calmer, 
shows affection, acceptance of peers and siblings 
respects parents, Obedient etc... 
Male ASD Our son seems to have calmed down after several 
sessions 
Female Mild Asperger’s 
Syndrome 
Needs more time to see effectiveness 
Male ASD I noticed that our son has increased in his 
vocabulary a lot and is now communicating much 
better. Now he can also describe a situation that 
happened when we were not present. Actually he 
is now enjoying communicating. In the past few 
days he also started to decide what he wants and 
communicate his decisions too, which is a very 
positive step. 
Female PDD Increased academically 
Table 1: Parents feedback.
Subject Alpha 
Before 
Alpha 
After 
Beta 
Before 
Beta After Delta 
Before 
Delta 
After 
1 652 1960 801 1452 506 322 
2 515 775 1066 789 1235 1019 
3 15 6 28 78 164 149 
4 917 140 850 653 857 107 
5 6 309 50 1201 729 470 
6 640 251 586 981 535 377 
7 907 28 166 160 946 206 
8 1088 485 1514 631 984 441 
Table 2: Before and after Alpha, Beta and Delta peak levels. This data was used 
for statistical analysis to test the significant change over the period of time the BMS 
was used.
Paired t-Test for Before and After Alpha
Alpha Before Alpha After 
Mean 592.5 494.25 
Variance 162717.4286 414583.9286 
Observations 8 8 
Pearson Correlation 0.098090614 
Hypothesized Mean Difference 0
df 7
t Stat 0.383037635 
P (T<=t) one-tail 0.356529119 
t Critical one-tail 1.894578605 
P (T<=t) two-tail 0.713058238 
t Critical two-tail 2.364624252 
Paired t-Test for Before and After Beta
Beta Before Beta After
Mean 632.625 743.125 
Variance 280739.125 224851.8393 
Observations 8 8 
Pearson Correlation 0.237225587 
Hypothesized Mean Difference 0 
df 7 
t Stat -0.502800961 
P(T<=t) one-tail 0.315267166 
t Critical one-tail 1.894578605 
P(T<=t) two-tail 0.630534333 
t Critical two-tail 2.364624252 
Paired t-Test for Before and After Delta
Delta Before Delta After 
Mean 744.5 386.375 
Variance 112743.1429 83050.83929 
Observations 8 8 
Pearson Correlation 0.604452096 
Hypothesized Mean Difference 0 
df 7 
t Stat 3.608078927 
P (T<=t) one-tail 0.004323133 
t Critical one-tail 1.894578605 
P (T<=t) two-tail 0.008646265 
t Critical two-tail 2.364624252 
Table 3: Paired t-Test results for data from Table 2.
Figure No. Figure description 
Figures 6-13 These figures represent the data analysis obtained from using 
the algorithm created. Three figures show mean voltage of all 
sessions, number of peaks and standard deviation from mean 
for Alpha, Beta and Delta waves for all subjects respectively. 
Figure 14 and 15 These figures represent lines showing how peak levels of 
Delta waves change throughout the sessions 
Figure 16 and 17 These figures represent lines showing how peak levels of 
Alpha waves change throughout the sessions 
Figure 18 and 19 These figures represent lines showing how peak levels of 
Beta waves change throughout the sessions 
Figures 20-22 All the data collected was represented as a percentage and all 
subject’s data was plotted in one graph for comparison. 
Table 4: Figure explanation.
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Figure 6: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 1.
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Figure 7: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 2.
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Figure 8: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 3.
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Figure 9: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 4.
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Figure 10: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 5.
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Figure 11: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 6.
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Figure 12: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 7.
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Figure 13: (a) mean voltage of sessions, (b) number of peaks during sessions, (c) Standard deviation from mean voltage for subject 8.
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tend to be more focused since their levels of β wave peaks increase. 
Figures 15,17 and 19 represent how α, β and δ wave peaks tend to 
behave over a longer period of time while using the NF device. These 
two subjects submitted more daily reports than others thus we have 
more data on the effect of the BMS device. These two subjects are 
of more clinical interest due to the opportunity to analyze the long-
term effect of the BMS. α and β wave peak levels tend to be promoted 
and increase with respect to previous levels in most of the sessions as 
demonstrated by the respective figures. However, of more interest in 
this study is the result obtained in Figure 15 which demonstrates how δ 
wave peaks tend to be lowered over time.
A paired t-Test was done on data recorded before and after a 
period of NF training to test if the Null hypothesis could be rejected 
[21]. This data represents the peak levels of α, β and δ respectively and 
is shown in Table 2. Results for this test are shown in Table 3 and it 
could be concluded that for α before and after, the Null-Hypothesis 
is not rejected since t-Stat is <t Critical one-tail [21]. This implies that 
statistical difference could or could not have occurred in the period 
of time. On the other hand, the results demonstrate very positive 
 
Figure 14: Delta waves in 5 of the subjects in this study(should u label 
the axis? Hz vs what?).
Figure 15: Delta wave peaks in the 3 other subjects.
Figure 16: Alpha wave peaks in 5 of the subjects in this study.
Figure 17: Alpha wave peaks in the other 3 subjects.
Figure 18: Beta wave peaks in 5 of the subjects in this study.
 
Figure 19: Beta wave peaks in the other 3 subjects in this study.
Figure 20: Graph representing Alpha wave peaks of all subject with 
respect to the percentage of the duration in which analysis was done.
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statistical relevance for β and δ wave peak levels before and after the 
NF training period. For the β wave peak levels, the Null-Hypothesis 
is rejected since t-Stat is >t Critical one-tail and therefore there is 
statistical difference [21] i.e. β wave levels have increased over the 
period of time. The most important result from this study shows that 
δ wave levels have been suppressed and there is statistical difference 
before and after NF training. In fact, the Null-Hypothesis is rejected 
since t-Stat is >t Critical one-tail & P (T<=t) two-tail is smaller than 
alpha (0.05) which demonstrates that there is statistical difference 
between before and after data [21].
To summarize the results of this study performed on children 
diagnosed with ASD, all participants in this trial demonstrated 
behavioral improvement. Literature states that patients suffering from 
ASD tend to have atypical functional brain asymmetries which are the 
cause of different activity in hemispheres causing lower α and β waves 
while keeping high δ waves activity. The children who participated in 
this study used the BMS device and the result was that δ waves were 
suppressed and α and β waves were promoted leading to a lower peak 
count of δ waves and higher peak counts of α and β waves respectively.
Conclusion
The presented study gave positive and coherent results. The use of the 
BMS for children suffering from ASD showed significant improvement 
of the child’s behaviour and interaction. A paired t-Test also supported 
the main aim of the study, i.e. to suppress δ waves in the subject’s brain 
activity. The results show that there is statistical difference before and 
after the NF training period. To support this statement, apart from all 
Figure 21: Graph representing Beta wave peaks of all subject with respect 
to the percentage of the duration in which analysis was done.
 
Figure 22: Graph representing Delta wave peaks of all subject with respect 
to the percentage of the duration in which analysis was done.
the analysis done, close relatives of the children subjected to this paper 
also confirmed the significant improvement in their children’s social 
behaviour. As for future work, comparing the BMS music therapy 
together with other complimentary therapies should be encouraged.
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